What the FDA proposed on April 30, 2026 directly affects the availability and legal status of compounded semaglutide and tirzepatide
Foley partners Nate Beaver, co-chair of the firms Medical Devices Area of Focus, and David Rosen, leader of the firms FDA Practice Group, will discuss what the future has in store for compounded GLP-1 drugs
The convenience of administering GLP-1 receptor agonists at home allows patients to self-manage their conditions under the guidance of healthcare professionals, ultimately supporting better adherence to therapy
Negin (Aug 18, 2025)
Its Longitudes third and final company launched from its first cohort, which includes specialty pharmacy, value-based specialty care, and now RCM
They will evaluate whether youre experiencing a B12 deficiency or could benefit from the injections for energy, metabolism, or overall health